Back to search results

Study of RECONJOINT for Breast Reconstruction Surgery

This study is looking at a tool called RECONJOINT, which is designed to help people make decisions about breast reconstruction surgery. The main goal is to see if it's practical to conduct a larger study on how well RECONJOINT works. You might be able to join if you are 18 or older, have a genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer, and are considering breast reconstruction after a mastectomy. The study aims to enroll 131 participants. We don't know the current recruitment status.

Study design
This is an interventional study planning to enroll 131 participants. It is not specified if it is randomized or blinded.
What's involved
The primary goal is to measure feasibility within 60 days after your initial reconstructive surgery consultation and before your breast reconstruction surgery.
Compensation
Not stated in the trial record.
Follow-up
The study measures feasibility within 60 days after your initial reconstructive surgery consultation and before your breast reconstruction surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07335354

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Recruiting
NAAges 18+Interventional
Memorial Sloan Kettering Cancer Center
~131 participants
Updated 2026-07-09 on ClinicalTrials.gov
What's tested:RECONJOINT

At a glance

Recruiting sites
8 of 9 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility determined by participant accrual
Measured over <60 days after initial reconstructive surgery consult and before pt's breast reconstruction surgery

Conditions

Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

9 sites across 3 states
New York4
New Jersey3
North Carolina2

Study leadership

  • Evan Matros, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Evan Matros, MD
[email protected]
646-608-8044
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
≥18 years old
Considering post-mastectomy breast reconstruction
A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
≥18 years old
Considering post-mastectomy breast reconstruction
Have an appointment scheduled for consultation with a plastic surgery provider
Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.

Exclusion

Not considering post-mastectomy breast reconstruction
Non-English proficiency
Not considering postmastectomy breast reconstruction
Recurrent or metastatic breast cancer
Male sex
Non-English proficiency
Does not provide breast reconstruction care at least 50% of the time
Non-English proficiency

What this trial measures

  • Feasibility determined by participant accrual<60 days after initial reconstructive surgery consult and before pt's breast reconstruction surgery

    Determine the feasibility of a hybrid effectiveness-implementation study that investigates the effectiveness and implementation potential of a decision aid to improve shared decision-making in breast reconstruction.